medroxyprogesterone acetate has been researched along with Menopause in 216 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (29.17) | 18.7374 |
| 1990's | 70 (32.41) | 18.2507 |
| 2000's | 53 (24.54) | 29.6817 |
| 2010's | 22 (10.19) | 24.3611 |
| 2020's | 8 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, JH | 1 |
| Cagnacci, A; Facchinetti, F; Fontanesi, F; Neri, I; Palma, F; Xholli, A | 1 |
| Brynhildsen, J; Fredrikson, M; Hammar, M; Hoffmann, M; Spetz Holm, AC; Sundell, M | 1 |
| Deng, Y; Huang, H; Jin, H; Shi, J | 1 |
| Crandall, CJ; Manson, JE; Mehta, JM | 1 |
| Chlebowski, RT; Coday, M; Johnson, KC; Jung, SY; LaMonte, MJ; LeBoff, MS; Manson, JE; Michael, YL; Mouton, CP; Pan, K; Peila, R; Richey, P; Rohan, TE; Saquib, N; Shadyab, AH; Wactawski-Wende, J; Xue, X | 1 |
| Bluming, AZ; Hodis, HN; Langer, RD | 1 |
| Bassuk, SS; Kaunitz, AM; Manson, JE; Pinkerton, JV | 1 |
| Archer, DF; Hodis, HN; Langer, RD; Lobo, RA; Pickar, JH; Pines, A; Sarrel, PM; Simon, JA; Utian, WH | 1 |
| Bhupathiraju, SN; Grodstein, F; Hu, FB; Manson, JE; Rosner, BA; Stampfer, MJ; Willett, WC | 1 |
| Chen, Q; Hong, Q; Kuang, Y; Lu, X; Mao, X; Wang, Y; Zhang, J | 1 |
| Deng, Y; Gao, L; Sun, A; Wang, Y; Xue, W; Zheng, T; Zuo, H | 1 |
| Chai, W; Chen, Q; Fan, Y; Fu, Y; Guo, H; Kuang, Y; Lyu, Q; Wen, X; Xie, J; Yan, Z; Yu, B; Zhou, L | 1 |
| Coupland, C; Hippisley-Cox, J; Vinogradova, Y | 1 |
| Spark, MJ | 1 |
| Simon, JA | 1 |
| McLaren, JS; Morris, EP; Rymer, J; Simpson, PD | 1 |
| Feng, G; Feng, Y; Li, H; Peng, S | 1 |
| Bergendal, A; Hirschberg, AL; Kieler, H; Kocoska-Maras, L; Sundström, A | 1 |
| Bahamondes, L; Castro, S; Ferreira, JM; Monteiro, I; Silveira, C; Villarroel, M | 1 |
| Chen, FL; Deng, Y; Jiang, JF; Sun, AJ; Wang, YF; Wang, YP; Xue, W; Zhang, Y; Zheng, TP | 1 |
| Mejía, A; Palacios, S | 1 |
| Bevilacqua, E; Brunelli, R; Capri, O; Ceci, F; Ciarla, MV; Galoppi, P; Perrone, G; Strom, R | 1 |
| Fournier, A; Weiderpass, E | 1 |
| Allison, M; Anderson, GL; Brzyski, R; Jackson, RD; Johnson, KC; Kuller, LH; Lane, DS; Langer, RD; Manson, JE; Ockene, J; Pettinger, M; Prentice, RL; Rossouw, JE; Sarto, G; Wactawski-Wende, J | 1 |
| Bimonte-Nelson, HA; Bowman, BL; Braden, BB; Crain, ID; Lukas, RJ; Prokai, L; Scheldrup, MR; Simard, AR; Talboom, JS | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Smit, JA | 1 |
| Anderson, ML; Chlebowski, RT; Keiser, E; Larson, JC; Spaunhurst, KM; Stefanick, ML; Tang, JY; Thomas, F; Wactawski-Wende, J; Zeitouni, NC | 1 |
| Castanho, VS; de Faria, EC; Gidlund, M; Nakamura, R | 1 |
| Cravioto, MD; Durand-Carbajal, M; Jiménez-Santana, L; Lara-Reyes, P; Sánchez-Guerrero, J; Seuc, AH | 1 |
| Allan, GM; Korownyk, C; McCormack, J | 1 |
| Geber, S; Souza, BM; Souza, MA | 1 |
| Hemminki, E; Luoto, R; Regushevskaya, E; Veerus, P | 1 |
| Enserink, M | 1 |
| Thacker, HL | 1 |
| Hyde, BM; Wilborn, WH | 1 |
| Sparrow, M | 1 |
| Kaunitz, A; Nelson, A; Schnare, S; Wysocki, S | 1 |
| Reid, RL | 1 |
| Couzin, J; Enserink, M | 1 |
| Fernández del Castillo, C | 1 |
| Barnabei, VM; Cauley, JA; Grady, D; Lin, F; Pickar, JH; Stefanick, ML; Stovall, DW; Stuenkel, CA | 1 |
| Romero, M | 1 |
| Breckwoldt, M | 1 |
| Beksinska, ME; Farley, TM; Guidozzi, F; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
| Appt, SE; Clarkson, TB | 1 |
| Aisaka, K | 1 |
| Huang, MT; Jiang, YX; Lin, SQ; Zhang, Y; Zhou, YZ | 1 |
| Adams, SM; Gayer, N; Hosie, MJ; Murphy, CR; Terry, V | 1 |
| Athayde, C; Coutinho, EM; Maia, H; Maltez, A; Studard, E | 1 |
| Bäckström, T; Bixo, M; Jonsson, B; Odmark, IS | 1 |
| Dalsgaard, T; Lund, CO; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 1 |
| Brochu, M; Cooper, BC; Fairhurst, PA; L'Hommedieu, GD; Sites, CK; Toth, MJ | 1 |
| Rutqvist, LE; von Schoultz, E | 1 |
| Birkhaeuser, MH | 1 |
| Caufriez, A; Foidart, JM; Genazzani, AR; Kuttenn, F; Lignières, Bd; Modena, MG; Mueck, AO; Sismondi, P; Verhaeghe, J | 1 |
| Barad, DH; Barnabei, VM; Brzyski, RG; Cochrane, BB; Gass, M; Hays, J; Lane, DS; Larson, JC; Manson, JE; Ockene, JK; Rosal, MC; Wassertheil-Smoller, S; Wylie-Rosett, J | 1 |
| Petitti, DB | 1 |
| Singh, M | 1 |
| Ehrlich, K; Grothaus, L; Guiltinan, J; Lacroix, AZ; Ludman, E; Newton, KM; Reed, SD | 1 |
| Danby, FW | 1 |
| Bonanni, B; Cazzaniga, M; Daldoss, C; Decensi, A; Feroce, I; Guerrieri-Gonzaga, A; Mariani, L; Mora, S; Ramazzotto, F; Serrano, D | 1 |
| Barton, D; Bearden, JD; Dakhil, SR; Fitch, TR; Kugler, JW; Levitt, R; Loprinzi, CL; Mailliard, JA; Nikcevich, DA; Sloan, JA; Tschetter, LK | 1 |
| Shulman, LP | 1 |
| Edwards, D; Gibbs, RB; Lazar, N; Nelson, D; Talameh, J | 1 |
| Eren, S; Kutlu, T; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Avci, R; Develioğlu, O; Kaymaz, C; Uncu, G; Uncu, Y | 1 |
| Ehrlich, K; Grothaus, LC; Guiltinan, J; LaCroix, AZ; Newton, KM; Reed, SD | 1 |
| Blumenfeld, Z; Boulman, N; Leiba, R; Levy, Y; Linn, R; Shachar, S; Siegler, E | 1 |
| Shapiro, S | 1 |
| Lobo, RA | 1 |
| Burriss, SW; Gast, MJ; Maki, PM; Vieweg, AJ; Yaffe, K | 1 |
| Bahamondes, L; Castro, S; Fernandes, A; Juliato, CT; Marchi, NM; Olivotti, B | 1 |
| Campidelli, C; Cinelli, F; Contini, P; Di Scioscio, V; Fabiani, A; Pileri, SA; Schiavina, M; Zompatori, M | 1 |
| Bastert, G; Michel, RT | 1 |
| Abe, O; Enomoto, K; Izuo, M; Kubo, K; Nomura, Y; Takatani, O; Tominaga, T | 1 |
| Boschitsch, E; Gitsch, E; Spona, J | 1 |
| Ingle, JN | 1 |
| Grönroos, M; Johansson, R; Kangas, L; Mäenpää, J; Nieminen, AL; Vanharanta, R | 1 |
| Alberto, P; Cavalli, F; Goldhirsch, A; Jungi, F; Martz, G | 1 |
| Friedrich, ER; Meyer, JS | 1 |
| Buhi, WC; Dougherty, MC; Notelovitz, M; Ware, MD | 1 |
| Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
| Graziottin, A; Marchetti, M; Onnis, A | 1 |
| Bottari, SP; Kaivez, E; Lescrainier, JP; Vauquelin, GP; Vokaer, A | 1 |
| Maggino, T; Marchesoni, D; Mozzanega, B | 1 |
| Lobo, RA; McCormick, W; Roy, S; Singer, F | 1 |
| Doorenbos, H; Pratt, JJ; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Fernández-Aparicio, MA; Medina, M; Pérez-Palacios, G; Ulloa-Aguirre, A; Zacarías-Villareal, J | 1 |
| Lammintausta, R; Punnonen, R; Viinamäki, O | 1 |
| Chávez, B; Escobar, N; Larrea, F; Lince, M; Pérez, AE; Pérez-Palacios, G; Vilchis, F | 1 |
| Blümel, JE; Brandt, A; Estartus, A; Gramegna, G; Roncagliolo, ME; Tacla, X; Vásquez, R | 1 |
| Aono, T; Hata, K; Irahara, M; Sunahara, S; Uemura, H; Yasui, T; Yoneda, N | 1 |
| Klimenchenko, NI | 1 |
| Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Ferri, L; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Omodei Zorini, C | 1 |
| Johnson, SH; Olsson, SE; Svensson, LO | 1 |
| Ces, J; Codesido, J; González, M; Macía, M; Novo, A; Quintana, S | 1 |
| Biberoğlu, KO; Kandemir, O; Yildiz, A | 1 |
| Healy, DL; Wingfield, M | 1 |
| Bruschi, F; Crosignani, P; Fumagalli, R; Meschia, M; Morrisett, JD; Paoletti, R; Soma, MR | 1 |
| Heikkinen, J; Hietala, EL; Larmas, M; Väänänen, HK | 1 |
| Liu, JL | 1 |
| Bar, J; Fuchs, J; Goldberger, S; Ovadia, J; Pardo, Y; Tepper, R | 1 |
| Folsom, AR; Heiss, G; Nabulsi, AA; Patsch, W; Szklo, M; White, A; Wu, KK | 1 |
| Crosignani, P; Fumagalli, R; Meschia, M; Morrisett, JD; Osnago-Gadda, I; Paoletti, R; Soma, MR | 1 |
| Christiansen, C; Dequinze, B; Deroisy, R; Franchimont, P; Gaspard, U; Reginster, JY; Taquet, AN | 1 |
| Colacurci, N; De Placido, G; Locci, M; Montemagno, U; Zullo, F | 1 |
| Cedars, MI; Eggena, P; Gambone, JC; Greendale, GA; Judd, HL; Lozano, K; Pang, SC | 1 |
| Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Guerin, D; Guerin, R | 1 |
| Beard, RW; Cooper, S; Gangar, KF; Rae, T; Rogers, V; Saunders, D; Stones, RW | 1 |
| Mattsson, LA; Samsioe, G; Uvebrant, M; von Schoultz, B; Wiklund, I | 1 |
| Boschitsch, E; Egarter, C; Geurts, P; Huber, J; Speiser, P | 1 |
| Bar, J; Beyth, Y; Fuchs, J; Goldberger, S; Ovadia, J; Tepper, R | 1 |
| Brunelli, R; Doria, G; Fattorossi, A; Frasca, D; Perrone, G; Pioli, C; Zichella, L | 1 |
| Albertazzi, P; Bonaccorsi, G; Campobasso, C; De Paoli, D; Giulini, NA; Pansini, F; Pisati, R; Zanotti, L | 1 |
| Heikkinen, J; Kurttila-Matero, E; Kyllönen, E; Lankinen, KS; Rita, H; Väänänen, HK; Wilén-Rosenqvist, G | 1 |
| D'Antona, D; De Leo, V; De Palma, P; Lanzetta, D; Morgante, G | 1 |
| Baba, K; Fukuda, M; Higuchi, A; Ikeda, K; Matsuda, M; Matsuoka, Y; Nagao, K; Nishimura, R; Yamashita, H | 1 |
| Anklesaria, BS; Bhathena, RK; Ganatra, AM; Pinto, R | 1 |
| Menozzi, G | 1 |
| Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V | 1 |
| Aygen, EM; Başbuğ, M; Kaya, E; Tayyar, M | 1 |
| Abellán Alemán, J; García Sánchez, FA; Leal Hernández, M; Martínez Selva, JM | 1 |
| Barillaro, F; Capri, O; Critelli, C; Galoppi, P; Liu, Y; Perrone, G; Zichella, L | 1 |
| Campana, A; Chmouliovsky, L; Golay, A; Habicht, F; James, RW; Lehmann, T | 1 |
| Ernst, U; Hauser, GA | 1 |
| Abellán Alemán, J; Carbonell Meseguer, LF; Díaz Fernández, J; García Sánchez, FA; Leal Hernández, M; Martínez Selva, JM | 1 |
| Cabero, A | 1 |
| Jaszczak, P; Planellas, J; Poulsen, HK; Saure, A | 1 |
| D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V | 1 |
| Spencer, AP | 1 |
| Acs, N; Miklós, Z; Monos, E; Nádasy, GL; Székács, B; Tökés, AM; Vajó, Z; Várbíró, S | 1 |
| Archer, DF; Pickar, JH | 1 |
| Binder, EF; Jeffe, DB; Kohrt, WM; Schechtman, KB; Williams, DB | 1 |
| Dastidar, P; Jaakkola, O; Jokela, H; Koivu, TA; Koivula, T; Lehtimäki, T; Nikkari, ST; Punnonen, R | 1 |
| Battistutta, D; Coglan, M; Khoo, SK; Raphael, B; Tippett, V | 1 |
| Baber, R; Heller, GZ; Nand, SL; Webster, MA | 1 |
| Chambers, HM; Kirkgard, Y; MacLennan, A; MacLennan, AH; O'Neill, S; Wenzel, S | 1 |
| Berger, BM; Berger, MJ; Brown, EM; Curtis, K; el-Hajj Fuleihan, G; Gleason, R; LeBoff, MS | 1 |
| Diamant, YZ; Kleinman, Y; Livshin, Y; Reisin, A; Tadmor, OP | 1 |
| Campobasso, C; De Paoli, D; Giulini, D; Levato, F; Pansini, F; Serra, MM | 1 |
| Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I | 1 |
| Bertolli, V; Boschetti, C; Cortellaro, M; Della Volpe, A; Nencioni, T; Zanussi, C | 1 |
| Campodónico, I; Valdivia, I | 1 |
| Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
| Bellantoni, MF; Blackman, MR; Cho, DE; Harman, SM | 1 |
| Canova, N; Longhi, A; Martoni, A; Pannuti, F | 1 |
| Houjou, T; Kadota, K; Mori, N; Wada, T; Watatani, M; Yasutomi, M | 1 |
| Byrjalsen, I; Thormann, L | 1 |
| Braly, PS; Feldesman, MR; Gosink, BB; Lin, MC; Pretorius, DH; Stuenkel, CA; Wolf, SI | 1 |
| Ames, R; Cundy, T; Evans, M; Reid, IR; Roberts, H; Wattie, D | 1 |
| Heikkinen, J; Kurttila-Matero, E; Kyllönen, E; Takala, T; Väänänen, HK; Vuori, J | 1 |
| Bellantoni, MF; Blackman, MR; Cullins, VE; Engelhardt, SM; Harman, SM | 1 |
| Confino-Cohen, R; Lang, R; Lishner, M; Ravid, M; Savin, H | 1 |
| Bologna, A; Dal Magro, L; Dal Pozzo, M; Fiscon, D; Marchesoni, D; Mozzanega, B | 1 |
| Namer, M | 1 |
| Clisham, PR; de Ziegler, D; Judd, HL; Lozano, K | 1 |
| LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
| Sherwin, BB | 1 |
| Gallagher, JC; Goldgar, D; Kable, WT | 1 |
| Meyer, JE; Ravnikar, VA; Stomper, PC; Van Voorhis, BJ | 1 |
| Imaoka, S; Inaji, H; Koyama, H; Noguchi, S; Yamamoto, H | 2 |
| Biakhov, MIu; Meshcheriakova, NG; Vasiuta, NIu; Voznyĭ, EK | 1 |
| King, RJ; Lane, G; Whitehead, MI | 1 |
| Doihara, H; Kurita, A; Moriwaki, S; Saeki, H; Soga, H; Takashima, S; Takiyama, W; Tanada, M; Yokoyama, N | 1 |
| Feng, DD; Ge, QS; Lin, SQ; Wang, HL; Yao, FY | 1 |
| Cauley, J; Egeland, GM; Guzick, D; Kelsey, SF; Kuller, LH; Matthews, KA | 1 |
| Avioli, LV; McCracken, R; McMurtry, C; Pacifici, R; Peck, WA; Rifas, L; Vered, I | 1 |
| Becher, R; Gerhold, U; Hirche, H; Höffken, K; Miller, AA; Schmidt, CG | 1 |
| Deligdisch, L; Goodman, HM; Kredentser, D | 1 |
| Donát, J; Reslová, T | 1 |
| Buzdar, AU; Fritsche, HA; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, SW | 1 |
| Mouridsen, HT | 1 |
| Burnett, LS; Hargrove, JT; Maxson, WS; Wentz, AC | 1 |
| Bender, PR; Hagerman, DD; Moore, LG; Pickett, CK; Regensteiner, JG; Weil, JV; Woodard, WD | 1 |
| Carleo, J; Hendrix, JW; Luciano, AA; Turksoy, RN | 1 |
| Aksel, S; Prough, SG; Shepherd, J; Wiebe, RH | 1 |
| Bewtra, C; Gallagher, JC; Kable, WT | 1 |
| Figueroa-Casas, PR; Schlaen, I | 1 |
| Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D | 1 |
| Abe, O; Enomoto, K; Izuo, M; Kubo, K; Nomura, Y; Takatani, O; Tominaga, T; Yoshida, M | 1 |
| Elder, MG; Philipson, KA; White, JO | 1 |
| Bonte, J; Ide, P; Janssens, JP | 1 |
| Grant, B; Marcus, R; Minkoff, JR; Young, G | 1 |
| Schweitzer, MJ; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
| Fotherby, K | 1 |
| Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE | 1 |
| King, RJ; Whitehead, MI | 1 |
| Manni, A | 1 |
| Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE | 1 |
| Hellberg, D; Nilsson, S | 1 |
| Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
| Carlson, RW; Hannigan, JF; Hendrickson, C; Kohler, M; McWhirter, K; Tan, YO | 1 |
| Brema, F; Canobbio, L; Crivellari, D; Di Fronzo, G; Fassio, T; Galligioni, E; Gasparini, G; Monfardini, S; Talamini, R; Villalta, D | 1 |
| Baroni, M; Longhi, A; Martoni, A; Pannuti, F; Piana, E | 1 |
| Hisamatsu, K; Nomura, Y; Tashiro, H; Toi, M | 1 |
| Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F | 1 |
| Barnes, RB; Lobo, RA; Roy, S | 1 |
| Gibbons, WE; Lobo, RA; Mishell, DR; Moyer, DL; Roy, S | 1 |
| King, RJ; Lane, G; Pryse-Davies, J; Ryder, TA; Siddle, NC; Whitehead, MI | 1 |
| Dawood, MY; Khan-Dawood, FS; Ramos, J | 1 |
| Glick, JH; Haller, DG | 1 |
| Eggertsen, R | 1 |
| Alapin-Rubillovitz, S; Casper, RF | 1 |
| Blijham, GH; Mellink, WA; Meulenberg, PM; Van Deijk, WA | 1 |
| Cremer, P; Kruse, B; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H | 1 |
| Miura, S; Murai, H; Yoshida, M | 1 |
| Farabegoli, G; Martoni, A; Pannuti, F; Piana, E | 1 |
| Bryman, I; Ivarsson, E; Samsioe, G | 1 |
| Adams, JS; Endres, DB; Lobo, RA; Roy, S; Rude, RK; Shoupe, D; Singer, FR | 1 |
19 review(s) available for medroxyprogesterone acetate and Menopause
| Article | Year |
|---|---|
Management of Menopausal Symptoms: A Review.
Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism | 2023 |
'Tis but a scratch: a critical review of the Women's Health Initiative evidence associating menopausal hormone therapy with the risk of breast cancer.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Quality of Life; United States; Women's Health | 2023 |
Minimising menopausal side effects whilst treating endometriosis and fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Receptors, LHRH; Uterine Neoplasms | 2015 |
Progestogen safety and tolerance in hormonal replacement therapy.
Topics: Animals; Breast Neoplasms; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Progestins; Risk | 2016 |
Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Topics: Chemistry, Pharmaceutical; Climacteric; Drug Combinations; Drug Compounding; Drug Monitoring; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Medroxyprogesterone Acetate; Menopause; Osteoporosis, Postmenopausal; Patient Care Planning; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators | 2002 |
MPA and postmenopausal coronary artery atherosclerosis revisited.
Topics: Animals; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral; Coronary Vessels; Estrogens; Female; Haplorhini; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Models, Biological; Postmenopause; Risk | 2003 |
Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.
Topics: Aged; Breast Neoplasms; Confidence Intervals; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Research Design; Survivors; Sweden | 2005 |
New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Topics: Administration, Cutaneous; Administration, Oral; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Randomized Controlled Trials as Topic; Risk Assessment | 2005 |
Mechanisms of progesterone-induced neuroprotection.
Topics: Aging; Alzheimer Disease; Animals; Female; Humans; Medroxyprogesterone Acetate; Menopause; Neurons; Neuroprotective Agents; Ovariectomy; Progesterone; Signal Transduction; Women's Health | 2005 |
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
Topics: Androstenes; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Women's Health | 2006 |
Recent epidemiological evidence relevant to the clinical management of the menopause.
Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; United States; Venous Thromboembolism; Women's Health | 2007 |
Menopause and stroke and the effects of hormonal therapy.
Topics: Aged; Estrogen Replacement Therapy; Estrogens; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Stroke; United States; Venous Thrombosis; Women's Health | 2007 |
[Effects of replacement hormonal therapy on the cardiovascular system of postmenopausal women].
Topics: Adult; Age Factors; Aged; Cardiovascular System; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progestins; Sex Factors | 1995 |
Endometriosis: medical therapy.
Topics: Danazol; Endometriosis; Estrogens; Female; Gestrinone; Goserelin; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone Acetate; Menopause; Pelvic Pain; Pregnancy; Pregnancy Outcome; Reproductive Techniques; Severity of Illness Index; Treatment Outcome | 1993 |
The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Topics: Adult; Age Factors; Body Weight; Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hemostasis; Humans; Lipid Metabolism; Medrogestone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Premenopause; Progesterone Congeners | 1996 |
Hormone replacement therapy should be administered as secondary prevention of coronary artery disease.
Topics: Aged; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Long-Term Care; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone Congeners; Randomized Controlled Trials as Topic | 2000 |
Endometrial thickness after menopause: effect of hormone replacement.
Topics: Biopsy; Dilatation and Curettage; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors; Ultrasonography | 1991 |
Benefits and risks of menopausal estrogen and/or progestin hormone use.
Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms | 1988 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
73 trial(s) available for medroxyprogesterone acetate and Menopause
| Article | Year |
|---|---|
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials.
Topics: Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Exercise; Female; Humans; Medroxyprogesterone Acetate; Menopause; Women's Health | 2023 |
The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
Topics: Aged; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Women's Health | 2020 |
Efficacy and safety evaluation of Cimicifuga foetida extract in menopausal women.
Topics: Beijing; Cimicifuga; Estradiol; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Metabolic Syndrome; Middle Aged; Phytotherapy; Plant Extracts; Progesterone; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2018 |
The effects of hormone replacement therapy on dry eye syndromes evaluated by Schirmer test depend on patient age.
Topics: Adult; Age Factors; Double-Blind Method; Dry Eye Syndromes; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lacrimal Apparatus; Medroxyprogesterone Acetate; Menopause; Middle Aged; Tears | 2016 |
[Analysis of the effects on menopausal symptoms, quality of Life, and cardiovascular risk factors of five different therapy in women at early stage of menopause].
Topics: Cardiovascular Diseases; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Perimenopause; Progesterone; Quality of Life; Risk Factors | 2016 |
Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Blood Coagulation Factors; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Factor VII; Female; Fibrinolysis; Follow-Up Studies; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies | 2009 |
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Contraceptive Agents, Female; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progestins; Pulmonary Embolism; Retrospective Studies; Risk Factors; Stroke; Survival Rate; Thrombosis; Time Factors; Washington | 2009 |
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Topics: Aged; Confounding Factors, Epidemiologic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Melanoma; Menopause; Middle Aged; Odds Ratio; Proportional Hazards Models; Risk Assessment; Risk Factors; Skin Neoplasms; Women's Health | 2011 |
Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor Analysis, Statistical; Female; Humans; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Menopause; Mexico; Middle Aged; Patient Selection; Principal Component Analysis; Progestins; Risk Assessment; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vasomotor System | 2011 |
Progesterone increases resistance of ophthalmic and central retinal arteries in climacteric women.
Topics: Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ophthalmic Artery; Placebos; Prospective Studies; Retinal Artery; Rheology; Ultrasonography, Doppler; Vascular Resistance; Vasoconstrictor Agents | 2013 |
Variability of bothersome menopausal symptoms over time--a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT).
Topics: Drug Therapy, Combination; Estonia; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Hot Flashes; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Prevalence; Quality of Life; Self-Assessment; Socioeconomic Factors; Surveys and Questionnaires; Vasomotor System; Women's Health | 2012 |
Menopausal symptoms in older women and the effects of treatment with hormone therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Confidence Intervals; Evaluation Studies as Topic; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Satisfaction; Probability; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome | 2002 |
[Effect of vitamin K2 and estrogen administration on bone formation].
Topics: Amino Acids; Biomarkers; Bone Density; Bone Resorption; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Menopause; Osteocalcin; Osteogenesis; Osteoporosis; Treatment Outcome; Vitamin K 2 | 2004 |
[Monitoring the breast changes of Chinese postmenopausal women under long-term hormone replacement therapy by mammary ultrasonography].
Topics: Aged; Breast; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors; Ultrasonography, Mammary | 2004 |
Endometrial response to IVF hormonal manipulation: comparative analysis of menopausal, down regulated and natural cycles.
Topics: Adult; Biopsy; Endometrium; Epithelial Cells; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicular Phase; Hormones; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nafarelin; Progesterone | 2004 |
Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being.
Topics: Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Quality of Life; Sweden | 2004 |
The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.
Topics: Adipose Tissue; Blood Glucose; Body Composition; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Menopause; Middle Aged | 2005 |
Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.
Topics: Aged; Breast Neoplasms; Confidence Intervals; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Research Design; Survivors; Sweden | 2005 |
The Herbal Alternatives for Menopause (HALT) Study: background and study design.
Topics: Cimicifuga; Complementary Therapies; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Phytotherapy; Plant Preparations; Soybean Proteins | 2005 |
Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Topics: Administration, Cutaneous; Administration, Oral; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fenretinide; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2006 |
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cyclohexanols; Drug Therapy, Combination; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Triglycerides | 2007 |
The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
Topics: Cataract; Estrogens; Female; Hormone Replacement Therapy; Humans; Intraocular Pressure; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Tears | 2006 |
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.
Topics: Cimicifuga; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Compliance; Phytotherapy; Placebos; Plant Preparations; Soy Foods; Vasomotor System | 2006 |
Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
Topics: Cognition Disorders; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone Acetate; Memory; Memory Disorders; Menopause; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Placebos; Treatment Failure | 2007 |
Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Postmenopause; Prospective Studies; Reference Values | 2007 |
[Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menopause, Premature; Middle Aged; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Placebos | 1983 |
Additive hormonal therapy in women with advanced breast cancer.
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Estrogens; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Random Allocation; Tamoxifen | 1984 |
Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer.
Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation; Time Factors | 1984 |
[Double-blind method of the effect of menopause symptoms, lipid profile, and endometrial thickness of continuous therapy with estradiol valerate and medroxyprogesterone acetate].
Topics: Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone Congeners | 1994 |
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Time Factors | 1994 |
Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavailability study in menopausal women.
Topics: Administration, Oral; Biological Availability; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Reference Values; Single-Blind Method | 1994 |
Hormonal agents used in lowering lipoprotein(a).
Topics: Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Lipids; Lipoprotein(a); Male; Medroxyprogesterone Acetate; Menopause; Middle Aged; Receptors, LDL; Sex Characteristics; Time Factors | 1994 |
The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women.
Topics: Adult; Analysis of Variance; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Menopause; Middle Aged; Regression Analysis | 1993 |
Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
Topics: Administration, Cutaneous; Administration, Oral; Amino Acids; Bone Resorption; Creatinine; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Radioimmunoassay | 1993 |
Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Estradiol; Female; Gonadotropins; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Sex Hormone-Binding Globulin; Time Factors | 1993 |
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: the effects on lipoprotein metabolism in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Climacteric; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1993 |
The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Topics: Adult; Age Factors; Body Weight; Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hemostasis; Humans; Lipid Metabolism; Medrogestone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Premenopause; Progesterone Congeners | 1996 |
The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Blood Platelets; Cells, Cultured; Clomiphene; Epinephrine; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Postmenopause; Progesterone Congeners | 1996 |
Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium.
Topics: Administration, Cutaneous; Adult; Biopsy; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medrogestone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1996 |
HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
Topics: Bone Density; Cholesterol; Cholesterol, LDL; Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Exercise Therapy; Female; Femur; Humans; Isometric Contraction; Lipid Metabolism; Lipids; Lumbar Vertebrae; Medroxyprogesterone Acetate; Menopause; Middle Aged; Muscle Contraction; Muscle, Skeletal; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies | 1997 |
Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women.
Topics: Administration, Cutaneous; Adult; Climacteric; Contraception; Cyproterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norprogesterones; Progesterone; Progestins | 1997 |
Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen; Soft Tissue Neoplasms; Treatment Outcome | 1997 |
The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Topics: Administration, Cutaneous; Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Data Interpretation, Statistical; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone Congeners | 1998 |
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms | 1998 |
A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Topics: Administration, Oral; Blood Pressure; Climacteric; Desogestrel; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Mood Disorders; Placebos; Progesterone Congeners; Sweating; Uterine Hemorrhage | 2000 |
[The effects of menopausal replacement therapy in women with uterine myomas].
Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms | 1999 |
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Acceptance of Health Care; Uterine Hemorrhage | 2000 |
Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Topics: Aged; Analysis of Variance; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Risk Factors; Triglycerides | 2001 |
Hormonal treatment and psychological function during the menopausal transition: an evaluation of the effects of conjugated estrogens/cyclic medroxyprogesterone acetate.
Topics: Adult; Anxiety; Depression; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Dropouts; Placebos; Surveys and Questionnaires | 1998 |
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
Topics: Adult; Affect; Breast; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Female; Headache; Humans; Libido; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nausea; Pain; Vaginal Diseases; Vasomotor System | 1998 |
Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
Topics: Adult; Aged; Blood Pressure; Body Weight; Delayed-Action Preparations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Prospective Studies | 1992 |
Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism.
Topics: Bone Density; Delayed-Action Preparations; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies | 1992 |
Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation Factors; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors | 1991 |
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Topics: Aged; Aging; Body Mass Index; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Prospective Studies; Random Allocation; Survival Rate | 1991 |
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index; Body Weight; Delayed-Action Preparations; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Placebos; Vagina | 1991 |
Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
Topics: Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1991 |
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
Topics: Affect; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Sexual Behavior; Testosterone | 1991 |
Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Topics: Bone Density; Cholesterol; Contraceptive Agents, Female; Drug Synergism; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Triglycerides | 1991 |
How to improve adjuvant treatment results in postmenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Tamoxifen; Vincristine | 1989 |
Combined effects of female hormones and metabolic rate on ventilatory drives in women.
Topics: Adult; Drug Interactions; Estrogens, Conjugated (USP); Female; Humans; Hypercapnia; Hypoxia; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Oxygen Consumption; Physical Exertion; Pregnancy; Respiration | 1989 |
Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
Topics: Antineoplastic Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Random Allocation; Uterine Hemorrhage | 1988 |
A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer.
Topics: Adult; Androstanols; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Random Allocation | 1985 |
Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Random Allocation; Tamoxifen | 1986 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
Topics: Adult; Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1987 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence | 1988 |
Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
Topics: Adult; Aged; Androgens; Cholesterol, HDL; Cholesterol, LDL; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Triglycerides | 1985 |
Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically-induced postmenopausal women.
Topics: Adult; Calcifediol; Calcitonin; Calcitriol; Calcium; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parathyroid Hormone; Progestins | 1985 |
127 other study(ies) available for medroxyprogesterone acetate and Menopause
| Article | Year |
|---|---|
The Role of Progestogens in Menopausal Hormone Therapy.
Topics: Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Progestins | 2021 |
Treatment of menopausal symptoms: concomitant modification of cortisol.
Topics: Animals; Climacteric; Estrogen Replacement Therapy; Female; Horses; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Menopause | 2021 |
Pulmonary embolism in menopausal hormone therapy: a population-based register study.
Topics: Administration, Cutaneous; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Progestins; Pulmonary Embolism; Risk Factors | 2022 |
Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis.
Topics: Breast Neoplasms; Computational Biology; Estradiol; Estrogen Receptor Antagonists; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Molecular Docking Simulation; Progesterone; Progestins; Proto-Oncogene Proteins p21(ras); Receptors, Estrogen; Transcription Factors | 2022 |
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.
Topics: Breast Neoplasms; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Primary Prevention; Risk Factors; Time Factors; United States; Women's Health | 2017 |
Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Chronic Disease; Comparative Effectiveness Research; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasms; Postmenopause; Risk Factors; State Medicine; Time Factors; Women's Health | 2017 |
Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
Topics: Birth Weight; Child; Congenital Abnormalities; Embryo Transfer; Female; Fertilization in Vitro; Gestational Age; Humans; Infant, Newborn; Live Birth; Medroxyprogesterone Acetate; Menopause; Menotropins; Ovulation Induction; Parturition; Perinatal Mortality; Pregnancy; Pregnancy Outcome; Retrospective Studies; Twins; Vitrification | 2017 |
The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development.
Topics: Animals; Disease Models, Animal; Female; Hormones; Humans; Medroxyprogesterone Acetate; Menopause; Menotropins; Mice; Mice, Inbred BALB C; Ovarian Follicle; Ovulation Induction; Random Allocation; Signal Transduction; Treatment Outcome | 2018 |
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Topics: Administration, Cutaneous; Adult; Aged; Case-Control Studies; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; United Kingdom; Venous Thromboembolism | 2019 |
Is progesterone a synonym for medroxyprogesterone acetate?
Topics: Female; Humans; Medroxyprogesterone Acetate; Menopause; Ophthalmic Artery; Retinal Artery; Vascular Resistance | 2014 |
What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?
Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone; Randomized Controlled Trials as Topic; Risk Assessment; Venous Thromboembolism; Women's Health | 2014 |
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Odds Ratio; Perimenopause; Postmenopause; Progestins; Risk Factors; Sweden; Vagina; Venous Thromboembolism | 2016 |
The Use of Long Acting Reversible Contraceptives and the Relationship between Discontinuation Rates due to Menopause and to Female and Male Sterilizations.
Topics: Adolescent; Adult; Brazil; Child; Contraceptive Agents, Female; Female; Humans; Long-Acting Reversible Contraception; Male; Medroxyprogesterone Acetate; Menopause; Middle Aged; Sterilization, Reproductive; Young Adult | 2016 |
ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
Topics: Coronary Disease; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause | 2008 |
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women.
Topics: Adult; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Life Style; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Sweden; Women's Health | 2009 |
Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats.
Topics: Animals; Contraceptive Agents, Female; Female; gamma-Aminobutyric Acid; Hippocampus; Medroxyprogesterone Acetate; Memory Disorders; Menopause; Ovariectomy; Rats; Rats, Inbred F344 | 2010 |
Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone | 2011 |
Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Autoantibodies; Autoimmune Diseases; Cardiovascular Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Epitopes; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipase; Lipoprotein Lipase; Lipoproteins, LDL; Medroxyprogesterone Acetate; Menopause; Middle Aged; Oxidation-Reduction; Oxidative Stress | 2011 |
Bioidentical hormone micronized progesterone.
Topics: Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone; Progestins | 2012 |
Women's health. The vanishing promises of hormone replacement.
Topics: Breast Neoplasms; Cardiovascular Diseases; Colorectal Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Menopause; Postmenopause; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Selection Bias; Time Factors | 2002 |
The case for hormone replacement: new studies that should inform the debate.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Disease; Depression; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Assessment; Risk Factors | 2002 |
Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Endometrium; Estrogens; Estrone; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Medroxyprogesterone Acetate; Menopause; Physiology; Reproduction; Reproductive Control Agents; Therapeutics; Urogenital System; Uterus | 1983 |
Contraception in the perimenopause.
Topics: Coitus Interruptus; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Disease; Family Planning Services; Intrauterine Devices; Medroxyprogesterone Acetate; Menopause; Progesterone Congeners; Reproduction; Signs and Symptoms; Spermatocidal Agents; Sterilization, Reproductive | 1992 |
Frequent urination and Depo-Provera. Ask the experts.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Medroxyprogesterone Acetate; Menopause; Physiology; Reproduction; Urogenital System | 1998 |
Translating the latest scientific advances into clinical practice.
Topics: Breast Neoplasms; Coronary Disease; Diffusion of Innovation; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Gynecology; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Selection; Practice Patterns, Physicians'; Risk Factors; Stroke; Time Factors | 2002 |
Women's health. More questions about hormone replacement.
Topics: Clinical Trials as Topic; Drug Combinations; Drug Labeling; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; National Institutes of Health (U.S.); Risk Factors; United Kingdom; United States | 2002 |
[The confidence that women have in a gynecologist....].
Topics: Adolescent; Adult; Child; Drug Combinations; Estrogens, Conjugated (USP); Female; Gynecology; Hormone Replacement Therapy; Humans; Life Style; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Pregnancy; Progesterone Congeners; Risk Factors | 2002 |
Postmenopausal hormones: where do we go from here?
Topics: Clinical Trials as Topic; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Progestins; Research Design | 2003 |
[Hormone replacement therapy in menopause].
Topics: Aged; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Myocardial Infarction | 2003 |
Hormone therapy. A year in review.
Topics: Decision Making; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Women's Health | 2003 |
Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Predictive Value of Tests | 2003 |
Effect of previous hormone replacement therapy on endometrial polyps during menopause.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Polyps; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Retrospective Studies | 2004 |
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Topics: Acetylcholine; Animals; Arteries; Calcium; Coronary Vessels; Disease Models, Animal; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Menopause; NG-Nitroarginine Methyl Ester; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Progestins; Rabbits; Vasoconstriction; Vasodilation | 2004 |
The Women's Health Initiative conundrum.
Topics: Adult; Age Factors; Aged; Bias; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Selection; Progesterone Congeners; Research Design; Stroke; United States; Women's Health | 2005 |
Symptom experience after discontinuing use of estrogen plus progestin.
Topics: Aged; Anxiety; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pain; Progestins; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Vasomotor System | 2005 |
Some surprises, some answers, and more questions about hormone therapy: further findings from the Women's Health Initiative.
Topics: Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Progestins; Substance Withdrawal Syndrome | 2005 |
Management of menopause-related symptoms.
Topics: Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged | 2005 |
Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Dopamine; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Hormones; Hydroxyindoleacetic Acid; Macaca fascicularis; Medroxyprogesterone Acetate; Menopause; Norepinephrine; Norpregnenes; Ovariectomy; Serotonin | 2006 |
Summaries for patients. Treating symptoms of menopause: a study of the effectiveness of black cohosh alone and with other herbal therapies or soy.
Topics: Cimicifuga; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Compliance; Phytotherapy; Placebos; Plant Preparations; Soy Foods; Vasomotor System | 2006 |
High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Drug Administration Routes; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Inflammation; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Factors | 2007 |
Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients.
Topics: Adult; Estrogen Antagonists; Estrogens; Female; Hormones; Humans; Leuprolide; Luteolytic Agents; Lymphangioleiomyomatosis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Respiratory Function Tests; Triptorelin Pamoate | 2007 |
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma].
Topics: Administration, Oral; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Tablets | 1983 |
[Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local | 1982 |
Steroid receptors and response of ovarian cancer to hormones in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cystadenocarcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tamoxifen | 1984 |
Estrogen-progestin pharmacodynamics of the postmenopausal endometrium studied by thymidine labeling.
Topics: Autoradiography; Biopsy; Cell Division; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Thymidine; Tritium | 1982 |
Prolactin: effects of age, menopausal status, and exogenous hormones.
Topics: Adult; Aging; Castration; Estradiol; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin | 1982 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
Hormones and risk of breast cancer.
Topics: Adult; Breast Diseases; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pain; Risk; Thermography | 1983 |
Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium.
Topics: Binding, Competitive; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Myometrium; Prazosin; Pregnancy; Progesterone; Receptors, Adrenergic, alpha; Stereoisomerism; Yohimbine | 1983 |
GnRH-test after high-dose MPA in women with post-menopausal LH-preferential release.
Topics: Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Pituitary Gland; Receptors, Cell Surface; Receptors, LH; Stimulation, Chemical; Time Factors | 1983 |
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hydroxyproline; Immunosuppressive Agents; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Random Allocation | 1984 |
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients.
Topics: Adrenocorticotropic Hormone; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones | 1984 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
On the mechanism of action of progestins.
Topics: Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Androgen | 1981 |
Effect of medroxyprogesterone acetate and d-norgestrel on plasma renin activity, antidiuretic hormone, and urinary aldosterone in postmenopausal women.
Topics: Aged; Aldosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Renin; Time Factors; Vasopressins | 1981 |
Mechanism of action of contraceptive synthetic progestins.
Topics: Androgen-Insensitivity Syndrome; Animals; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norethindrone; Ovary; Rabbits; Rats; Receptors, Steroid; Sheep | 1981 |
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Radioimmunoassay; Uterine Hemorrhage | 1995 |
Progesterone challenge test for the assessment of endometrial pathology in asymptomatic menopausal women.
Topics: Biopsy; Endometrial Neoplasms; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity | 1993 |
Bone mineral density in Turkish postmenopausal women.
Topics: Adult; Bone Density; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Parity; Prospective Studies; Reference Values; Spine; Turkey | 1993 |
Effect of postmenopausal estrogen treatment on some diagnostic salivary variables.
Topics: Bacteria; Calcium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Menopause; Phosphorus; Placebos; Prospective Studies; Saliva; Secretory Rate | 1993 |
[Effect of nylestriol on postmenopausal uterine endometrium].
Topics: Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Quinestrol; Uterine Hemorrhage | 1993 |
The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women.
Topics: Adenosine Triphosphate; Blood Platelets; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Platelet Aggregation; Platelet Function Tests | 1993 |
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Topics: Apolipoproteins; Blood Coagulation Factors; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Factors | 1993 |
Uterine fibroids: protocols of integrated medical/surgical treatment.
Topics: Abortion, Habitual; Biopsy; Combined Modality Therapy; Estrogens, Conjugated (USP); Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Pregnancy; Uterine Neoplasms; Uterus | 1993 |
An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy.
Topics: Adult; Chronic Disease; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Hysterectomy; Medroxyprogesterone Acetate; Menopause; Pain Measurement; Patient Satisfaction; Pelvic Inflammatory Disease; Prospective Studies; Time Factors | 1993 |
Hormone replacement therapy affects various immune cell subsets and natural cytotoxicity.
Topics: Cytotoxicity, Immunologic; Estradiol; Estrogen Replacement Therapy; Female; Humans; Killer Cells, Natural; Lymphocyte Subsets; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1996 |
[The effect of hormone substitution therapy on body weight].
Topics: Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause | 1998 |
The effects of different doses of medroxyprogesterone acetate on serum lipids, lipoprotein levels and atherogenic index in the menopausal period.
Topics: Arteriosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Triglycerides | 1998 |
[Do our patients wish to receive hormone replacement therapy during menopause? Myths that persist].
Topics: Data Collection; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Acceptance of Health Care; Primary Health Care; Risk Assessment | 1998 |
Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy.
Topics: Adipose Tissue; Administration, Cutaneous; Aged; Aging; Body Composition; Body Constitution; Body Height; Body Mass Index; Body Weight; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parity | 1999 |
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women.
Topics: Cholesterol; Estradiol; Female; Glucose Tolerance Test; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Obesity; Triglycerides; Weight Loss | 1999 |
[Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)].
Topics: Adult; Climacteric; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone Congeners; Treatment Outcome | 1999 |
[Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment].
Topics: Adult; Analysis of Variance; Antioxidants; Bilirubin; Blood Glucose; Cardiovascular Diseases; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Progesterone Congeners; Risk Factors; Serum Albumin; Time Factors; Triglycerides | 2000 |
[Hot flashes, menopause, nitric oxide and hormone replacement therapy: "one for all and all for one"].
Topics: Adult; Animals; Antioxidants; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Postmenopause; Pregnancy; Progesterone Congeners; Risk Factors; Time Factors | 2000 |
Effect of ovariectomy and hormone replacement therapy on small artery biomechanics in angiotensin-induced hypertension in rats.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Elasticity; Estradiol; Female; Hormone Replacement Therapy; Hypertension; Medroxyprogesterone Acetate; Menopause; Ovariectomy; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Weight Gain | 2000 |
The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women.
Topics: Aged; Arteries; Arteriosclerosis; Autoantibodies; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins, LDL; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progesterone Congeners; Reference Values; Severity of Illness Index; Time Factors; Ultrasonography | 2001 |
The effects of two fixed hormonal replacement therapy protocols on blood lipid profile.
Topics: Clinical Protocols; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Prospective Studies | 1992 |
Combined use of progesterone challenge test and endometrium thickness evaluated by transvaginal ultrasonography in the preventive management of postmenopausal women.
Topics: Carcinoma; Endometrial Neoplasms; Endometrium; Female; Humans; Mass Screening; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone; Risk Factors; Ultrasonography | 1992 |
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms | 1992 |
[Cyclic ethinyl estradiol and medroxyprogesterone in climacteric women. Their clinicAL efficacy and patterns of uterine bleeding].
Topics: Climacteric; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Progesterone; Uterine Hemorrhage; Vaginal Smears | 1991 |
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |
[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Iron; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Retrospective Studies; Tegafur; Uracil | 1991 |
"Mad pursuits"--markers of cell activity?
Topics: Biomarkers; Biopsy; Delayed-Action Preparations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Pregnancy Proteins | 1991 |
Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis; Risk Factors; Smoking; Time Factors | 1991 |
Moderate exercise does not enhance the positive effect of estrogen on bone mineral density in postmenopausal women.
Topics: Bone Density; Estradiol; Estradiol Congeners; Exercise; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies | 1991 |
Response of carpal tunnel syndrome to hormone replacement therapy.
Topics: Carpal Tunnel Syndrome; Delayed-Action Preparations; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
Transdermal estrogen therapy in menopause. Eighteen months follow-up.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Body Weight; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
[Reflexions on hormone therapy of cancer of the breast].
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Ovariectomy; Tamoxifen | 1991 |
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
Topics: Adult; Aged; Breast; Delayed-Action Preparations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Retrospective Studies; X-Ray Intensifying Screens | 1990 |
Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Down-Regulation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone | 1990 |
[Hormonal control of disseminated breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
The histochemistry of oestradiol-17 beta dehydrogenase in normal endometrium and endometrial carcinoma: a test to predict the sensitivity of endometrial carcinoma to progestogens: a preliminary report.
Topics: 17-Hydroxysteroid Dehydrogenases; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Neoplasms | 1990 |
[Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones, Anterior; Receptors, Estrogen; Receptors, Progesterone | 1990 |
The effect of low-dose estrogen and progestogen on menopausal symptoms and urinary excretion of calcium.
Topics: Adult; Calcium; Creatinine; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1990 |
Hormone replacement therapy and lipoprotein changes during early menopause.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Multivariate Analysis; Risk Factors; Time Factors | 1990 |
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Topics: Adult; Cells, Cultured; Delayed-Action Preparations; Estrogens; Female; Humans; Interleukin-1; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Monocytes; Osteoporosis; Reference Values; Regression Analysis | 1989 |
High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1989 |
Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleus; Cytosol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Postmenopausal endometriosis associated with hormone replacement therapy. A case report.
Topics: Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Peritoneal Neoplasms | 1989 |
[Initial experience with centralized care of women with bleeding in the climacteric and postmenopausal period].
Topics: Climacteric; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Hemorrhage | 1989 |
Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone | 1989 |
Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
Topics: Cholesterol; Climacteric; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Progesterone | 1989 |
Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
Topics: Biopsy; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1988 |
Continuous estrogen/progestin therapy in menopause.
Topics: Biopsy; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Time Factors; Triglycerides | 1987 |
Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings.
Topics: Adult; Climacteric; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1988 |
The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
Topics: Creatine Kinase; Cytosol; Enzyme Activation; Female; Glucosephosphate Dehydrogenase; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1985 |
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms | 1986 |
Interactions of medroxyprogesterone acetate with estrogen on the calcium-parathyroid axis in post-menopausal women.
Topics: Adult; Aged; Calcium; Drug Therapy, Combination; Estrogens; Female; Humans; Hydroxyproline; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parathyroid Hormone | 1986 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO).
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain | 1986 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone | 1987 |
Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1987 |
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prognosis; Tamoxifen | 1987 |
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Remission Induction | 1987 |
[Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
Topics: Administration, Oral; Aged; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1988 |
Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women.
Topics: Biopsy; Cytosol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Receptors, Estrogen | 1986 |
Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
Topics: Biopsy; Delayed-Action Preparations; DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol Dehydrogenases; Estrogens, Conjugated (USP); Female; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Receptors, Estradiol | 1986 |
The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
Topics: Drug Therapy, Combination; Endorphins; Estrogens, Conjugated (USP); Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Naloxone; Prolactin | 1986 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
Influence on blood pressure of oestrogen substitution therapy in the menopause.
Topics: Aged; Blood Pressure; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Retrospective Studies | 1987 |
Progestins increase endogenous opioid peptide activity in postmenopausal women.
Topics: Aged; Endorphins; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Naloxone; Progestins; Prolactin | 1985 |
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Pilot Projects | 1985 |
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].
Topics: Aminoglutethimide; Breast Neoplasms; Cholesterol; Cortisone; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Triglycerides | 1985 |
[Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
Topics: Administration, Oral; Adult; Aged; Body Weight; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local | 1985 |
Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Delayed-Action Preparations; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin; Tamoxifen; Testosterone; Thyroid Hormones | 1985 |
Some anthropological aspects of the climacteric syndrome.
Topics: Climacteric; Drug Therapy, Combination; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors | 1985 |